Press Releases

November 26, 2008

Takeda Pharmaceutical Company Limited

Notice of Execution of Acquisition of the Company’s Own Shares

Osaka, Japan, November 26, 2008 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on October 20, 2008.

1. Class of shares acquired:	Shares of common stock
2. Period of acquisition:	From October 21, 2008 to November 25, 2008
3. Total number of shares acquired:	5,600,500 shares
4. Total value of acquisition:	Yen 25,931,663,000
5. Method of acquisition:	Purchased on the Tokyo Stock Exchange

(Reference)

Resolution of the Board of Directors on October 20, 2008

1.	Class of shares to be acquired:	Shares of common stock
2.	Number of shares to be acquired:	Up to 11 million shares (equivalent to 1.35% of the total issued shares)
3.	Total amount of shares to be acquired:	Up to 50 billion Yen
4.	Schedule of acquisition:	From October 21, 2008 to November 25, 2008

Treasury shares held by Takeda as of November 25, 2008

1. Aggregate number of issued shares:     (excluding treasury shares)	800,336,267 shares
2. Number of treasury shares:	14,816,128 shares

# # #